D-1484-2014 Class III Terminated

Recalled by Novel Laboratories, Inc. — Somerset, NJ

FDA drug recall D-1484-2014 was initiated by Novel Laboratories, Inc. on Jun 20, 2014 and is designated Class III. Reason for recall: Failed Impurity/Degradation Specification; 12-month stability time point The recall status is terminated (terminated Jun 29, 2015). Affected quantity: 25,776 containers.

Recall details

Product Type
Drugs
Report Date
Sep 3, 2014
Initiation Date
Jun 20, 2014
Termination Date
Jun 29, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
25,776 containers

Product description

Famotidine for Oral Suspension, USP 40 mg/5 mL, Rx Only, Cherry-Banana-Mint Flavored, Not for Injection, Manufactured by: Novel Laboratories, Inc., Somerset, NJ 08873. Distributed by: Gavis Pharmaceuticals, LLC, Somerset, NJ 08873, NDC 43386-500-11.

Reason for recall

Failed Impurity/Degradation Specification; 12-month stability time point

Distribution pattern

Nationwide

Code information

Lot #'s M13075A, M13076A, M13076B, M13077A, M13077B all with expiry dated 2/2015 and M13490A with expiry date 3/2016.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1484-2014
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1484-2014. Report a data issue: hello@regdatalab.com.